Skip to content
Search

Latest Stories

New study reveals how to ‘measure’ chronic pain using brain signals

New research has shown that chronic pain can be objectively measured using brain signals, a report in The Conversation said.

According to the report, a team of researchers conducted a study using brain implants capable of recording neural signals over an extended period.


Their aim was to identify reliable markers of chronic pain severity in four patients as they went about their daily lives.

While pain is typically a subjective experience, there is still much to discover about how pain signals are processed in the brain.

Previous studies often relied on artificial settings, and the relationship between acute and chronic pain circuits remained unclear.

To investigate this further, the researchers surgically implanted electrodes in the brains of four patients experiencing post-stroke pain and phantom limb pain.

Neural signals were recorded in specific brain regions associated with planning, expectation, and emotion.

The patients were then asked to report their pain severity levels multiple times a day for up to six months.

Machine learning models were developed to analyse the recorded brain activity signals and predict the patients’ self-reported pain intensity scores.

The findings unveiled a significant connection between low-frequency brain activity in the orbitofrontal cortex and the patients’ subjective pain intensities, providing an objective measure of chronic pain.

A greater shift in low-frequency activity indicated more intense pain.

Furthermore, a comparison between chronic pain and acute pain revealed distinct brain regions involved in processing each type of pain. This experiment shed light on the differences in information processing between acute and chronic pain.

Chronic pain affects a substantial portion of the population and has a higher prevalence than conditions like diabetes, high blood pressure, or depression. It poses challenges for effective treatment and can significantly impact both physical and emotional well-being.

Improved understanding of how to measure brain activity to track pain could lead to enhanced diagnosis and the development of novel treatments, such as deep brain stimulation.

While this study offers valuable insights into using specific brain regions as objective measures of chronic pain, there is still much more to uncover.

Pain signals are likely distributed across a wider brain network, and researchers are yet to determine other brain regions that may play vital roles in reflecting subjective pain.

Additionally, it remains uncertain whether the identified signals will apply to other types of pain conditions.

Looking ahead, the researchers aim to leverage these newly discovered neural biomarkers to create personalised brain stimulation approaches for treating chronic pain disorders.

This entails developing algorithms that incorporate the identified signals to govern the timing and location of brain stimulation, similar to how a thermostat operates.

More For You

US-UK pharmaceutical trade concerns as Liberal Democrat MPs urge protection from Trump tariffs.

UK prime minster Sir Keir Starmer with US president Donald Trump

Pic credit: Getty images

Pharma sector needs protecting from Trump tariffs, warn MPs

A group of Liberal Democrat MPs have written to health secretary Wes Streeting urging him to protect the pharmaceutical industry from US president Donald Trump’s trade war.

The five ministers from Oxfordshire, Olly Glover, Layla Moran, Calum Miller, Charlie Maynard, and Freddie van Mierlo, have warned that Trump’s campaign to raise tariffs has already led to “catastrophic damage”.

Keep ReadingShow less
Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less